Increased ENPP2 expression was detected in COVID-19 DCs and pDCs, correlating with markers of immature DCs (61), while an anti-inflammatory role of LPA has been previously proposed for DCs via LPAR2 (117), suggesting that ATX/LPA could be also involved in suppression of DC responses in COVID-19. Here, LPAR2 is linked to COVID-19.